37 results for "Hideya Kitamura"
Showing 1–20 · 0.68 seconds · RSS
-
Journal Article
Current State and History of the Measurement of Implicit Attitudes
Implicit attitudes in the field of social psychology are reviewed and explained. Distinguishing between implicit and explicit measures and how implicit measurements emerged are described. Attitude strength and accessibility were introduced through the research of Fazio et al., which served as a…
-
Journal Article
Development and Validation of the Purity Orientation–Pollution Avoidance Scale: A Study With Japanese Sample
The moral foundations theory (MFT) proposes that there are five moral foundations that work as the standard to make moral judgments. Among them, the purity foundation is a complex concept. It is considered to be a distinctive foundation compared with the other ones partly because it involves…
-
Journal Article Full text
Perception of Hidden Confidence in Neutral Expressions: Interactions of Facial Attractiveness, Self-Esteem, and Names to Be Addressed by
Even when a person is portraying a neutral expression, their internal feelings can be reflected subtly on their face, and observers can perceive them. A previous study took facial photographs of female models while wearing attractive and unattractive clothing. Although the models displayed neutral…
-
Journal Article
The Moderating Role of Psychological Essentialism in The Link Between Threat to Symbolic Purity and Exclusionary Attitudes Toward Foreigners
Purity is a component of morality, which relates to perceptions of cleanliness (i.e., physical aspect) and divinity (i.e., symbolic aspect). Purity violations threaten one’s traditional values and beliefs and motivate people to recover purity by avoiding something atypical. Like the physical aspect…
-
Journal Article
Oral Antifibrotic Agents for the Treatment of Idiopathic Pulmonary Fibrosis: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
Introduction: Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease marked by a decline in forced vital capacity (FVC). While nintedanib and pirfenidone are standard treatments, the benefits of newer drugs like nerandomilast and combination therapies remain unclear. This study employed…
-
Journal Article
Oral Antifibrotic Agents for the Treatment of Progressive Pulmonary Fibrosis: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
Introduction: Progressive pulmonary fibrosis (PPF) is a form of interstitial lung disease characterized by irreversible fibrotic progression and deteriorating lung function. Although antifibrotic agents approved for idiopathic pulmonary fibrosis (IPF) are used in PPF, their comparative efficacy and…
-
Journal Article
Predictors of survival and transplantation outcomes in Japanese patients with interstitial lung disease referred for lung transplantation: a retrospective single-center study
Abstract Background Lung transplantation is a vital therapeutic option for patients with advanced interstitial lung diseases (ILDs) unresponsive to conventional treatments. In Japan, challenges for this treatment include a long waiting period (average, 2.5 year) and the absence of a comprehensive…
-
Journal Article
Post-pneumonectomy-like syndrome as a result of unilateral upper-lung field pulmonary fibrosis after lung cancer surgery: a case report
Post-pneumonectomy syndrome is a rare complication following pneumonectomy, characterized as significant mediastinal shift and rotation toward the operated side, resulting in stenosis of trachea and bronchi.We report the case of a 60-year-old woman who underwent right lower lobectomy for lung…
-
Journal Article
Quantitative analysis of pathological findings identified clinical heterogeneity in nonspecific interstitial pneumonia with organising pneumonia overlap
Abstract The pathological classification of nonspecific interstitial pneumonia (NSIP) with organizing pneumonia (OP) overlap (NSIP/OP overlap) remains complex due to overlapping pathological features, and its heterogeneity is not well understood. We retrospectively analysed adult patients with…
-
Journal Article Full text
Pilot Quasi-Randomized Controlled Study of Herbal Medicine Hochuekkito as an Adjunct to Conventional Treatment for Progressed Pulmonary Mycobacterium avium Complex Disease
Introduction: Hochuekkito, a traditional herbal medicine, is occasionally prescribed in Japan to treat patients with a poor general condition. We aimed to examine whether this medicine was beneficial and tolerable for patients with progressed pulmonary Mycobacterium avium complex (MAC) disease…
Also available at: DOAJ
-
Journal Article
Patients with Terminal Interstitial Pneumonia Require Comparable or More Palliative Pharmacotherapy for Refractory Dyspnea than Patients with Terminal Lung Cancer
Background: Dyspnea is a severe symptom of terminal-stage interstitial pneumonia (IP). We commonly use continuous morphine or midazolam for terminal refractory dyspnea. Objective: We aimed to determine whether there is a difference in the use of continuous morphine and midazolam for terminal…
-
Journal Article
The new useful high-resolution computed tomography finding for diagnosing fibrotic hypersensitivity pneumonitis: “hexagonal pattern”: a single-center retrospective study
Abstract Background Centrilobular nodules, ground-glass opacity (GGO), mosaic attenuation, air trapping, and three-density pattern were reported as high-resolution computed tomography (HRCT) findings characteristic of fibrotic hypersensitivity pneumonitis (HP). However, it is often difficult to…
-
Journal Article Full text
Radiological and Pathological Features of Cyst Formation in Idiopathic Multicentric Castleman Disease
Introduction: Idiopathic multicentric Castleman disease (MCD) has been reported to form lung cysts at a relatively high rate. However, the radiological and pathological features of cystic formation in MCD are unclear. Methods: To clarify these questions, we retrospectively investigated the…
-
Journal Article
Usefulness and safety of transbronchial lung cryobiopsy for reassessment of treatment in the clinical course of diffuse parenchymal lung disease
Abstract Background The usefulness and safety of transbronchial lung cryobiopsy (TBLC) for reassessment of diffuse parenchymal lung disease (DPLD) with progression is still unknown. Our purpose was to clarify the usefulness and safety of TBLC for reassessment of DPLD with progression. Methods This…
-
Journal Article Full text
Clinical Features of Idiopathic Interstitial Pneumonia with Systemic Sclerosis-Related Autoantibody in Comparison with Interstitial Pneumonia with Systemic Sclerosis
Background: Patients with idiopathic interstitial pneumonias sometimes have a few features of connective tissue disease (CTD) and yet do not fulfil the diagnostic criteria for any specific CTD. Objective: This study was conducted to elucidate the characteristics, prognosis, and disease behavior in…
-
Journal Article
Latent inter-organ mechanism of idiopathic pulmonary fibrosis unveiled by a generative computational approach
Abstract Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive disease characterized by complex lung pathogenesis affecting approximately three million people worldwide. While the molecular and cellular details of the IPF mechanism is emerging, our current understanding is centered…
-
Journal Article
Emphysematous change with scleroderma-associated interstitial lung disease: the potential contribution of vasculopathy?
Abstract Background Pulmonary emphysema combined with systemic sclerosis (SSc)-associated interstitial lung disease (ILD) occurs more often in smokers but also in never-smokers. This study aimed to describe a new finding characterized by peculiar emphysematous change with SSc-associated ILD…
-
Journal Article
Safety and tolerability of nintedanib in patients with progressive fibrosing interstitial lung diseases: data from the randomized controlled INBUILD trial
Abstract Background In the INBUILD trial in patients with progressive fibrosing interstitial lung diseases (ILDs), nintedanib reduced the rate of decline in forced vital capacity compared with placebo, with side-effects that were manageable for most patients. We used data from the INBUILD trial to…
-
Journal Article
Integrated phenotyping identifies reproducible prognostic subgroups in idiopathic pleuroparenchymal fibroelastosis
Abstract Background Idiopathic pleuroparenchymal fibroelastosis (PPFE) is a rare interstitial lung disease characterized by upper-lobe–predominant fibrosis and heterogeneous prognosis. An integrated phenotype classification incorporating clinical, radiological and biological markers has not been…